-
Diagnostics World | Foresite Capital launches fund for three main areas: precision therapeutics, life science infrastructure, and healthcare delivery; Santa Ana Bio employs proteomic, transcriptomic, and genomic approaches to precisely characterize disease-specific subpopulations and identify targets only on disease-causing cell types leaving healthy cells unaffected; more.
Jun 27, 2024
-
Diagnostics World | PacBio, in collaboration with the international Consortium for Long-Read Sequencing (CoLoRS), announced the launch of the first publicly available and free HiFi long-read variant frequency database with global representation; PathAI unveiled two novel AI products, PathExplore Immuno-Oncology Profiling (IOP) and IHC Explore1; , Thermo Fisher Scientific has introduced One Lambda HLA PRO, an automated, modular pipetting system that offers versatility by accommodating different workflows on a single instrument, allowing laboratories to automate multiple human leukocyte antigen (HLA) and antibody testing technologies cost-effectively; more.
Jun 26, 2024
-
Diagnostics World | GRAIL, previously an Illumina company, began regular trading on Nasdaq today under the ticker symbol "GRAL." Illumina continues to trade on Nasdaq under the ticker symbol "ILMN."
Jun 25, 2024
-
Diagnostics World | Researchers at the Karolinska Institute in Stockholm, Sweden, have developed a new device for detecting malignant melanoma. Melanoma affects about one million people every year across the world, and over the past two decades, cases of melanoma have significantly increased due to higher rates of exposure to ultraviolet radiation and climate change.
Jun 21, 2024
-
Diagnostics World | Researchers in Israel who pioneered the discipline of “mechanomics” are now using the concept to fill the chasm between the expanding volume of ‘omics data and its translation into real-world clinical scenarios. Their aim is to help physicians predict the aggressiveness of cancer and a tumor’s potential resistance to treatment and, ultimately, improve patient outcomes.
Jun 18, 2024
-
Diagnostics World | Until recently, all the available therapeutic options for treating Alzheimer’s disease were designed to reduce symptoms rather than address causes of the disease. But with two beta-amyloid antibodies now approved by the U.S. Food and Drug Administration, and tau-targeting agents in clinical trials, hopes are rising that Alzheimer’s progression can be delayed if not stopped.
Jun 12, 2024
-
Diagnostics World | Sarcoidosis is difficult to diagnose for a variety of reasons. For one, it is not limited to a single area or part of the body. Although the vast majority of people living with sarcoidosis have it in their lungs, it can also appear in the eyes, the skin, brain, heart, spinal cord, liver, kidney, and even in the bones.
Jun 11, 2024